 {#s0002}

Establishment of Working Group team {#s0003}
-----------------------------------

In early 2014, the International Society of Arthroplasty Registries (ISAR) Steering Committee established 5 working groups to further enhance the aims of the society: (1) the Bylaws and Future Funding Committee, (2) the Data Quality and Harmonization Group, (3) the Scientific Committee, (4) the Quality Improvement Committee, and (5) the Patient-Reported Outcome Measures (PROMs) Working Group. The composition of the PROMs Working Group members was balanced to cover different continents, registry affiliations, and professions. This report reviews the rationale and features of PROMs for use in arthroplasty registries, and describes the results of a survey of arthroplasty registries about their current use of PROMs for hip and knee arthroplasty.

Rationale of work {#s0004}
-----------------

There are currently several large regional or national programs that collect and monitor PROMs before and after arthroplasty surgery (Department of Health [@C7], Rolfson et al. [@C21], [@C22], Franklin et al. [@C11]). These PROMs complement traditional outcomes data such as complications, adverse events, reoperations, and revisions. Although primary outcomes after joint replacement include pain relief and improved function, clinician-based tests may be biased and may not be valid to describe patient self-perceptions of health status. Despite having limitations, PROMs are the best tools available to measure patient-centered outcomes objectively.

The greater emphasis on PROMs in routine care during the last few years has been stimulated by the introduction of the concept of value-based healthcare, in which decisions about the best ways to deliver healthcare should be based on factors that add value for the patient (Porter [@C20]). Traditional measures are necessary, but PROMs are fundamental in understanding and evaluating healthcare from a value-based standpoint. Although revision surgery and major adverse events are rare complications, improvements are necessary because 10% to 20% of patients who have hip or knee replacement are dissatisfied with the outcome, mainly because of persistent pain and limited function (Rolfson et al. [@C21], Dunbar et al. [@C8]).

Mission and aim {#s0005}
---------------

The ISAR PROMs Working Group is an international panel of collaborators that was organized to convene, evaluate, and advise on best practices in the selection, administration, and interpretation of PROMs and to support the adoption and use of PROMs in hip and knee arthroplasty registries worldwide. Specific aims include advising about (1) which PROMs are best and most appropriate to use, (2) when to capture PROMs in relation to treatment, (3) data collection methods, (4) approach to analysis, and (5) optimal ways to present results. The Working Group also aims to (1) promote harmonization, to allow direct comparisons within and between centers over time, (2) avoid excessive complexity, and (3) ensure that standards are guided by research agendas and not by the special interests of companies or other funders of healthcare.  

Definitions {#s0006}
===========

Patient-reported outcomes and patient-reported outcome measures {#s0007}
---------------------------------------------------------------

A patient-reported outcome is defined as any report of a patient's health status that comes directly from the patient without interpretation by others. The PROMs are standardized instruments designed to measure specific phenomena or constructs of the health status of patients in defined populations (U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research et al. [@C25]). The term outcome may cause confusion because it implies a measurement that occurs only after an intervention. By definition, true outcomes involve the measurement of change and typically require repeated measures before---and/or at intervals after---interventions or during the disease course. Therefore, cross-sectional patient-reported measurements after treatment do not generate true outcomes.

Generic and specific patient-reported outcome measures {#s0008}
------------------------------------------------------

There are 2 main types of PROMs that are distinguished by different levels of focus. Generic (or general health) instruments are designed to provide a measure of general health for any health state, regardless of the presence or absence of illness, disability, or specific symptoms. Generic PROMs describe a patient's global health status that is comparable across different conditions.

Specific PROMs focus on specific symptoms, diseases, organs, body regions, or body functions. The specific PROMs may also be specifically designed to measure the effect of a specific intervention or treatment.

Methodological standards for the establishment of patient-reported outcome measures instruments {#s0009}
-----------------------------------------------------------------------------------------------

The establishment of a PROMs instrument requires the fulfillment of a set of methodological standards. The involvement of patients with methods such as interviews or focus groups to generate item content is important to ensure that the instrument will reflect the patient's standpoint and have valid content (U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research et al. [@C25]). The instrument must be tested rigorously to ensure that it is valid, reliable, responsive, and acceptable to the intended population. These properties are not fixed properties of an instrument but may relate to the population, the condition, or the treatment studied. The timing of questionnaire completions relative to the date of intervention may also affect the instrument's measurement properties.

After the content of a PROMs instrument has been established by the developers, none of the wording in the PROM may be changed, including word or item order. In addition to copyright issues, small changes in wording may change the perceived meaning of the items, and this may affect the measurement properties (Wild et al. [@C28], Rothman et al. [@C24]).

Validity {#s0010}
--------

Validity is the ability of an instrument to measure the intended outcome. A valid instrument adequately captures particular aspects of a person's health such as pain, mobility, or social functioning. Validity is an indication of the extent to which an assessment measures a particular construct in a particular situation, and a measure may be valid for one purpose but not another.

The different types of validity include content validity, which is the extent to which an instrument measures the intended concept. Content validity is specific to the population and treatment of interest. Content validity must be established before other measurement properties are evaluated, because other types of validity or reliability cannot overcome problems in content validity. Evidence to support content validity comes from qualitative studies that determine whether the items and domains of an instrument are appropriate and comprehensive relative to the intended measurement concept, population, and application. For PROMs, items and domains should reflect concerns of importance to most patients in the study. Content validity can be increased with (1) patient input in item generation, and (2) evaluation of patient understanding through cognitive interviews and pre-tests.

Criterion validity compares an instrument's measurement properties to a known standardized measure of the same construct, but such a measure may not exist. Construct validity is the extent to which an instrument forms pre-specified logical relations such as correlations between items or domains, and correlations to other established instruments or characteristics of patients or patient groups.

Reliability {#s0011}
-----------

Reliability has 2 elements: internal consistency and repeatability (also known as *reproducibility*). Internal consistency is the correlation between different items within a domain, and is a measure of the extent to which these items measure the concept of interest. Internal consistency is measured with Cronbach's alpha, a summary correlation; a high Cronbach alpha may indicate redundancy, and a low Cronbach alpha (\< 0.70) may indicate inconsistency. However, the optimal correlation as expressed with Cronbach's alpha may be difficult to define.

Repeatability (also known as *test-retest reliability*) is the stability of a measure over time. Repeatability is a measure of the random variability in a patient's responses to the same item when repeated measures are assessed under the same conditions and no real change has occurred. Repeatability can be evaluated with different statistical tests and is considered acceptable when the intraclass correlation coefficient is \>0.70.

Responsiveness {#s0012}
--------------

Responsiveness is defined as an instrument's ability to detect change when change has occurred. Adequate responsiveness is important for an instrument that is used to assess clinical changes. When a patient reports that a change has occurred, but the PROMs instrument score does not change, then the instrument may have inadequate ability to detect change or questionable validity.

Assessments of responsiveness of a measure require repeated assessments over time when the patient's condition of interest has changed. Condition- or context-specific measures are more responsive to changes in the condition of interest than generic measures, which may respond to other co-existing conditions increasingly with time.

In addition to showing that an instrument may detect change, it is useful to have an estimate of the minimal change of a measure, which is the smallest change that indicates that an important or meaningful change has occurred. An estimate of minimal change is needed to determine the real clinical or subjective meaning of any observed changes, whether or not the changes are statistically significant. Statistical significance depends, in part, on sample size. A small, clinically irrelevant, change may be statistically significant when the sample size is large. A large clinically relevant change may not be statistically significant in a small study (Petersen [@C19]).

Minimal change can be estimated as either the smallest amount of change that is of relevance to patients (minimal clinically important difference (MCID)) or the amount of change that is beyond simple measurement error (minimal detectable change (MDC)). The MCID is termed anchor-based, as it uses anchor questions to establish minimal change, and the MDC is distribution-based, i.e. based on statistical characteristics of the sample at issue. The MCID and MDC produce different estimates, but it is important that an estimate of minimal change that is produced using an anchor is larger than the measurement error of the instrument to confirm that the change is real (Jaeschke et al. [@C14], Wyrwich et al. [@C29]).

Acceptability and feasibility {#s0013}
-----------------------------

To optimize an instrument's properties, it is important to consider the burden to respondents and healthcare personnel in completing and administering questionnaires. Shorter measures that are written in clear, unambiguous language will encourage a higher frequency of response, which is often used as supporting evidence of the acceptability of a questionnaire.

Translations and cultural differences in response patterns {#s0014}
----------------------------------------------------------

The translation of a validated PROMs instrument into different languages requires a formal methodological approach and specific expertise (Wild et al. [@C28]). Such methods typically include consideration and testing of cultural equivalence, especially when there is no exact word or concept available in the target language or culture to match the word or concept that is used in the primary-language version of the measure being translated. Several steps are involved in the process of translating a PROMs instrument into another language, such as forward translation, reconciliation, back translation, harmonization, review, and cognitive debriefing (Wild et al. [@C28]).

The use of a PROMs instrument with different platforms, such as electronic (ePRO/ePROM) and hard-copy versions, may not be straightforward and may require changes in format or minor word changes, including instructions for completion. Recommendations for best practice are available for modification of the platform, including how much change in wording is considered minor (Coons et al. [@C4], Rothman et al. [@C24]).

The quality may vary between different translated or electronic versions of a PROMs instrument. When a translated version of a PROMs instrument is required for a specific language, it is therefore important to confirm that proper methods have been used and that the license holder supports a particular translated version. Caution is recommended in developing or adopting specific versions of ePROMs.

Other patient-reported measures related to health outcomes {#s0015}
----------------------------------------------------------

Satisfaction and similar measures: In addition to measures that directly address health status, there are useful patient-reported measures related to health outcomes such as measures of satisfaction with treatment effects, fulfillment of expectations, and willingness to repeat or recommend treatment to others. These interrelated measures are not true PROMs, by definition, and can be used only after an intervention or to evaluate something that has already occurred. Nevertheless, satisfaction and similar measures are associated with changes in PROMs scores and the patient's experience of care delivery. When true PROMs have inherent limitations that fail to determine treatment success, satisfaction items may be useful adjuncts.

Health transition: Health transition items are another category of patient-reported measures that address a self-perceived change over a defined period for a given construct. Health transitions can be used only retrospectively. Health transition items are often used in conjunction with health status measures, and may be incorporated into questions within a PROMs instrument, such as the Veterans RAND 12-item health survey (VR-12) question: "Compared to 1 year ago, how would you rate your physical health in general now?", which has 5 response options ranging from "much better" to "much worse". However, scores of health transition items are usually not incorporated into the overall PROMs score. As indicators of clinically important improvement or deterioration, transition items are commonly used to anchor changes in a particular scale. Response bias may occur from difficulty in recalling previous states and the tendency to accommodate, or due to changes in an individual regarding internal standards, values, or conceptualization---which is also known as response shift.

Survey of collection of patient-reported outcome measures in arthroplasty registries {#s0016}
====================================================================================

An e-mail survey was administered in September 2014 to full ISAR member registries (n = 12) and associate ISAR member registries (n = 29) to determine the current use of PROMs in arthroplasty registries. 8 registries administered a PROMs program that covered all elective hip or knee arthroplasty patients and 6 other registries collected PROMs for sample populations; 1 other registry had planned but had not started collection of PROMs (Table). The registries most often collected PROMs for research (n = 10), quality assurance (n = 8), or hospital assessment (n = 8). Some programs integrated their PROMs program in the clinic to provide input to caregivers for the care of individual patients (n = 6). Some registries used PROMs programs for assessment of surgeons (n = 4) and health regions (n = 4).

###### 

Survey responses of hip and knee arthroplasty registries that routinely collected patient-reported outcome measures[^a^](#TF1){ref-type="table-fn"}

  Registry                                           Joints included[^b^](#TF2){ref-type="table-fn"}   Patients included[^c^](#TF3){ref-type="table-fn"}   PROMs collected                               Satisfaction item                                                                        Frequency of patient response                        Data collection times                                                                                                                   
  -------------------------------------------------- ------------------------------------------------- --------------------------------------------------- --------------------------------------------- ---------------------------------------------------------------------------------------- ---------------------------------------------------- ------------------------------ ---------------------------------- ---------------------------------- ---------------------------------- ----------------------------------
  National registries                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
   Swedish Hip A R                                   \+                                                −                                                   All                                           EQ-5D                                                                                    Pain VAS                                             Yes VAS                        86                                 90                                 \+                                 1, 6, 10 y
   National J R (through NHS)                        \+                                                \+                                                  All                                           EQ-5D                                                                                    OHS/OKS                                              Yes                            80                                 80                                 \+                                 6 mo
   Swedish Knee A R                                  −                                                 \+                                                  Sample                                        EQ-5D                                                                                    KOOS, pain VAS                                       Yes, expectation fulfillment   90                                 80                                 \+                                 1 y
   New Zealand J R[^b^](#TF2){ref-type="table-fn"}   \+                                                \+                                                  Random 20% sample                                                                                                                      OHS/OKS                                              −                              NA                                 70--75                             −                                  6 mo, every 5 y
   Lithuanian A R                                    \+                                                \+                                                  Sample                                        EQ-5D                                                                                    HOOS/KOOS                                            −                              100                                60                                 \+                                 6 mo, 1 y
                                                                                                                                                                                                                                                                                                                                                                                      (of sample)                                                                                              
   Norwegian A R                                     \+                                                \+                                                  Occasional cross-sectional samples            EQ-5D                                                                                    HOOS/KOOS                                            Yes                            NA                                 80                                 −                                  1 to 2 y
   Dutch A R[^b^](#TF2){ref-type="table-fn"}         \+                                                \+                                                  All                                           EQ-5D, health transition                                                                 OHS/OKS, pain NRS                                    Yes                            50                                 50                                 \+                                 3 and 6 mo, 1 y
  National sample registries                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
   FORCE-TJR                                         \+                                                \+                                                  All                                           SF-36                                                                                    HOOS/KOOS, pain VAS                                  −                              80--85                             80--85                             \+                                 6 mo, annually
   American J R                                      \+                                                \+                                                  Not started[^d^](#TF4){ref-type="table-fn"}   EQ-5D, SF-12 or SF-36[^e^](#TF5){ref-type="table-fn"},[^f^](#TF6){ref-type="table-fn"}   WOMAC or HOOS/KOOS[^f^](#TF6){ref-type="table-fn"}   −                              [^d^](#TF4){ref-type="table-fn"}   [^d^](#TF4){ref-type="table-fn"}   [^f^](#TF6){ref-type="table-fn"}   [^f^](#TF6){ref-type="table-fn"}
  Local or regional registries                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   Harris J R                                        \+                                                \+                                                  All                                           EQ-5D                                                                                    Pain VAS, HHS/KOOS, UCLA                             Yes VAS                        [^g^](#TF7){ref-type="table-fn"}   [^g^](#TF7){ref-type="table-fn"}   \+                                 1, 3, 5, 7, and 10 y
   Register of the Orthopaedic Prosthetic            \+                                                −                                                   Sample                                        EQ-5D                                                                                    HOOS                                                 Yes                            30                                 80                                 \+                                 1 y
   Implants (Italy)--Michigan A R                    \+                                                \+                                                  All                                           SF-12[^e^](#TF5){ref-type="table-fn"}                                                    WOMAC, UCLA                                                                         32                                 12                                 \+ Annually                        
   Geneva A R                                        \+                                                \+                                                  All                                           SF-12[^e^](#TF5){ref-type="table-fn"}                                                    WOMAC, Pain VAS, UCLA                                Yes, willingness to repeat     71                                 65                                 \+                                 1, 5, 10, and 15 y
   Hospital for Special Surgery                      \+                                                \+                                                  All                                           SF-12[^e^](#TF5){ref-type="table-fn"}                                                    HOOS/KOOS                                            Yes                            80                                 75                                 \+                                 Annually
   California J R                                    \+                                                \+                                                  All                                           SF-12[^e^](#TF5){ref-type="table-fn"}                                                    WOMAC, UCLA                                          −                              70                                 70                                 \+                                 6 mo, 1 y, every 2 y

n = 15 registries (7 national registries, 2 national samples, and 6 local or regional registries). The survey was performed in September 2014. A R: Arthroplasty Register/Registry, J R: Joint (Replacement) Register

The New Zealand Joint Registry and the Dutch Arthroplasty Register were the only 2 registries that included shoulder, elbow, and ankle joint arthroplasty.

Patients included: all, all patients in a country, region or hospital; sample, sample of patients in a country, region, or hospital.

Not started; the American Joint Replacement Register were planning but had not started a PROMs program as of September 2014.

SF-12 or the similar Veterans RAND 12-item health survey (VR-12).

As preferred by healthcare provider.

Not Known

EQ-5D, EuroQol 5-dimension health outcome survey; FORCE-TJR, Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement; NA, not applicable, NHS, National Health Service, England; HOOS, Hip disability and Osteoarthritis Outcome Score; KOOS, Knee injury and Osteoarthritis Outcome Score; NRS, numeric rating scale; OHS, Oxford Hip Score; OKS, Oxford Knee Score; SF-12 (or 36), Short Form 12 (or 36) health survey; PROMs, patient-reported outcome measures; UCLA, University of California at Los Angeles Activity Score; VAS, Visual Analog Scale; WOMAC, Western Ontario and McMaster Universities Arthritis Index.

Different instruments were used by different registries (Table). The most common generic instruments were the EuroQol 5-dimension health outcome survey (EQ-5D) (EuroQol Group [@C10], EuroQol Group [@C9]) and the Short Form 12 health survey (SF-12) or the VR-12, which is similar (Ware et al. [@C26], Ware et al. [@C27], Kosinski et al. [@C15], Rolfson et al. [@C22], Boston University School of Public Health [@C2], Optum Inc. [@C18]). 9 registries (60%) collected a satisfaction item. The most common specific PROMs were the Hip disability and Osteoarthritis Outcome Score (HOOS) (Nilsdotter et al. [@C17]), the Knee injury and Osteoarthritis Outcome Score (KOOS) (Roos et al. [@C23]), the Oxford Hip Score (OHS) (Dawson et al. [@C5], Murray et al. [@C16]), the Oxford Knee Score (OKS) (Dawson et al. [@C6], Murray et al. [@C16]), the Western Ontario and McMaster Universities Arthritis Index (WOMAC) (Bellamy et al. [@C1]), and the University of California at Los Angeles Activity Score (UCLA) (Zahiri et al. [@C30]). Several registries reported use of a separate visual analog scale (VAS) or numeric rating scale (NRS) to measure joint pain (Breivik et al. [@C3], Hawker et al. [@C12], Hjermstad et al. [@C13]). Most registries collected preoperative measures and had several follow-ups, most commonly at 1 year after surgery. Preoperative PROMs were usually collected at an outpatient visit or preoperative class. Follow-up surveys were usually collected by regular mail (printed forms), but some registries also used e-mail, electronic (web) surveys, and telephone calls. Response frequencies for PROMs were in some cases approximate estimates and should be interpreted with caution. The variation in frequency of patient responses reflects the logistic challenges of collecting PROMs.

The ISAR PROMs Working Group thanks Elly Trepman for help in reorganizing the original ISAR PROMs Working Group internal report into 2 manuscripts.
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